gene in individuals relapsing soon after cure Along with the BCL2 antagonist venetoclax. 66 Resistance to those brokers has become related to these mutations in about 70% of situations, Despite the fact that they are generally subclonal and their distinct position resulting in resistance ought to be demonstrated.Genetic susceptibility mechanisms. M